CRSP compared with NTLA: revenue, margins and what each company keeps, and the suppliers and customers both name

CRSPCRISPR Therapeutics AG

Mkt capRevenueRevenue

NTLAIntellia Therapeutics, Inc.

Mkt capRevenueRevenue

Compare

CRSPCRISPR Therapeutics AG

NTLAIntellia Therapeutics, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Supply-chain overlap

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

CRSPCRISPR Therapeutics AG

50.08▲+3.13%· post 50.00

Mkt cap$4.9BRevenue$13MQ3 FY26Revenue$4MFY25

NTLAIntellia Therapeutics, Inc.

11.35▲+2.23%· post 11.31

ClosedNov 6 '26

Mkt cap$1.6BRevenue$7MQ3 FY26Revenue$68MFY25

Compare

ClosedNov 6 '26

CRSPCRISPR Therapeutics AG

NTLAIntellia Therapeutics, Inc.

50.08▲+3.13%post 50.00

Price

11.35▲+2.23%post 11.31

$4.9B

Mkt cap

$1.6B

Q3 FY26$13M

Revenue

$7MQ3 FY26

FY25$4M

Revenue

$68MFY25

CRSP50.08▲+3.13%vsNTLA11.35▲+2.23%ClosedNov 6 '26

Supply-chain overlap

direct ties · both sidesSources ›

direct ties · both sides

Only CRSP 5

LLYEli Lillycustomer

VRTXVertexcustomer

VERXVertex Pharmaceuticalscustomer

ACETAdicet Biocustomer

1 more · CRSP chain ›

Shared 0

No shared counterparties.

Only NTLA 4

REGNRegeneron Pharmaceuticalscustomer

CRBUCaribou Biosciencessupplier

—AvenCell Therapeuticsunlistedcustomer

—SparingVision SAS

Role chip = supplier or customer—= no ticker (unlisted)Source: SEC EDGAR

unlistedcustomer